Affective disorders (ICD-10 F30-F39), neurotic, stress-related and somatoform disorders (ICD-10 F40-F48), personality and behavioral disorders (ICD-10 F60-F69), behavioral and emotional disorders with onset in childhood and adolescence (ICD-10 F90-F98).
Conditions
Interventions
Group 1: To research the psychological characteristics of dissociative or functional disorders and to detect specific patterns, extensive diagnostics using questionnaires and structured interviews sho
Sponsors
Universitätsklinikum Bonn, Klinik und Poliklinik für Psychiatrie und Psychotherapie
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Arm 1: (Patients with dissociative and functional disorders): Adult patients up to and including 65 years of age with diagnoses in the areas of affective disorders (ICD-10 F30-F39), neurotic, stress-related, and somatoform disorders (ICD-10 F40-F48), behavioral disorders with somatic symptoms and factors (F50-F59), personality and behavioral disorders (ICD-10 F60-F69), and/or behavioral and emotional disorders with onset in childhood and adolescence (ICD-10 F90-F98). Arm 2 (Patients with neurological disorders): Adult patients up to and including 65 years of age with diagnoses from the areas of inflammatory diseases of the central nervous system (ICD-10 G00-G09), extrapyramidal diseases and movement disorders (ICD-10 G20-G26), episodic and paroxysmal diseases of the central nervous system (ICD-10 G40-G47) and/or with symptoms affecting the nervous system and the musculoskeletal system (ICD-10 R25-R29). Arm 3 (Patients with syncopal seizures): Adult patients up to and including 65 years of age with diagnoses of syncope and collapse (ICD-10 R55) and/or other unspecified seizures (ICD-10 R56.8).
Exclusion criteria
Exclusion criteria: All study arms: Younger than 18 or older than 65 years, lack of capacity to consent, acute suicidality, previous brain surgery. Certain infectious and parasitic diseases (ICD-10 A00-B99), malignant tumor diseases (ICD-10 C00-C97), organic mental disorders (ICD-10 F00-F09), serious mental and behavioral disorders due to psychotropic substances (from ICD-10 F10-F19), schizophrenia, schizotypal and delusional disorders (ICD-10 F20-F29), intellectual disabilities (ICD-10 F70-F79), developmental disorders (ICD-10 F80-F89), systemic atrophies predominantly affecting the central nervous system (ICD-10 G10-G14), other degenerative diseases of the nervous system (ICD-10 G30-G32), cerebrovascular diseases (ICD-10 I60-I69), pregnancy, childbirth and the postpartum period (ICD-10 O00-O99).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is the psychopathological characterization of patients with dissociative and functional disorders in the areas of personality, quality of life, self-efficacy, traumatic experiences and stress-related disorders, dissociative symptoms and self-perception, depressive symptoms and alexithymia, emotion regulation, anxiety, anger and aggression symptoms, empathy, hyperkinetic symptoms, somatic complaints, activities of daily living, sense of coherence, coping and resilience, health literacy and level of functioning, vocabulary and intelligence, genetic risks, handedness, sociodemographics, and general clinical parameters. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary comparisons will be made with healthy subjects as well as with patients suffering from either structural neurological diseases or syncope. | — |
Countries
Germany
Contacts
Public ContactMax Christian Pensel
Universitätsklinikum Bonn, Klinik und Poliklinik für Psychiatrie und Psychotherapie
Outcome results
None listed